Glucotrack, Inc. Issues Shareholder Update under Regulation FD

What Happened On September 23, 2026, Glucotrack, Inc., a Delaware corporation, filed a Form 8-K under Item 7.01 (Regulation FD Disclosure) to furnish a shareholder update. The update was provided as Exhibit 99.1 to the filing. The 8-K does not report earnings, revenue, executive changes, or any financial statements.

Key Details

• Filing date: September 23, 2026 (Form 8-K, Item 7.01—Regulation FD Disclosure).
• Exhibit attached: 99.1 — Shareholder Update dated September 23, 2026.
• The filing did not include financial statements or report quarterly earnings, revenue, mergers, or officer appointments.
• A cover page interactive data file (inline XBRL) was included per Exhibit 104.

Why It Matters This filing signals that Glucotrack has publicly shared a shareholder communication; Regulation FD disclosure means the information was broadly released to investors and the market. The 8-K itself does not disclose financial results or corporate changes, so investors should review Exhibit 99.1 (the shareholder update) and monitor subsequent filings for any material financial or operational developments.